Market Outlook
By 2035, the U.S. Volumetric Infusion Pumps Market is expected to reach approximately USD 1.33 billion, expanding at a CAGR of 9.20% during the forecast period 2026–2035. The market was valued at approximately USD 0.55 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.
The historical market expanded from approximately USD 0.36 billion in 2021 to USD 0.49 billion in 2024, supported by normalization of hospital procedure volumes after the pandemic, modernization of infusion fleets, rising utilization of smart drug-error reduction systems, increasing oncology and antimicrobial infusion demand, and renewed investment in connected medication-management infrastructure. In 2025, the market reached approximately USD 0.55 billion as U.S. health systems accelerated replacement of aging large-volume pumps and increasingly evaluated infusion platforms on interoperability, cybersecurity, drug-library performance and total fleet economics.
Volumetric infusion pumps occupy a strategically important position in U.S. acute-care medication delivery because they administer precisely controlled volumes of intravenous fluids, medications, blood products, parenteral nutrition and other therapies across intensive care units, medical-surgical floors, emergency departments, operating rooms, oncology departments and specialty infusion environments. Although the pump itself is a capital or durable medical device, the commercial opportunity extends well beyond the installed hardware base. Administration sets, software licensing, drug-library management, wireless infrastructure, analytics, biomedical engineering services and multiyear enterprise contracts create recurring revenue around the pump fleet.
The market is increasingly shifting from stand-alone electromechanical pumping toward digitally connected infusion management. A modern volumetric infusion platform is expected to communicate with the electronic health record, accept hospital-specific drug libraries, enforce dose-error reduction limits, support auto-programming, transmit infusion documentation, generate fleet-utilization data and operate within increasingly demanding cybersecurity environments. For hospital procurement committees, these capabilities are becoming as important as flow accuracy and mechanical reliability.
The forecast through 2035 therefore reflects more than simple growth in the number of pumps deployed. Revenue expansion will also be driven by premiumization of smart connected systems, replacements prompted by safety or obsolescence concerns, higher software and service content per installation, standardization across integrated delivery networks and recurring demand for proprietary or platform-specific infusion sets.
Introduction
According to the U.S. Volumetric Infusion Pumps Market Report, volumetric pumps are among the most frequently utilized medication-delivery technologies in the hospital environment. They are particularly suited to therapies requiring controlled administration of comparatively large fluid volumes over defined periods and therefore represent an essential component of routine and high-acuity care.
The underlying addressable infrastructure is substantial. The United States operates more than 6,000 hospitals and approximately 900,000 staffed hospital beds, while annual hospital admissions exceed 35 million. Every large health system must maintain significant infusion capacity across inpatient nursing units, critical care, emergency medicine, perioperative care and specialty treatment departments. A 500-bed tertiary hospital can require hundreds or potentially thousands of infusion channels once simultaneous therapy requirements, backup inventory, transport needs, intensive care complexity and fleet rotation are considered.
Demand is also supported by the clinical intensity of U.S. inpatient care. Approximately 1.7 million adults experience sepsis annually, making time-sensitive IV antibiotics, vasopressors, fluids and other infusion therapies fundamental to acute management. U.S. cancer incidence exceeded two million newly diagnosed cases in 2025, creating additional infusion demand through chemotherapy, immunotherapy, supportive medications, hydration, antiemetics, antibiotics and blood-product administration.
The commercial market, however, is more complex than disease prevalence alone suggests. Volumetric infusion pumps are part of a closed medication-use process involving pharmacy, nursing, information technology, clinical engineering, biomedical engineering, procurement, infection prevention, cybersecurity and hospital administration. Changing a pump platform may require redesigning hundreds or thousands of drug-library entries, validating EHR interfaces, training large clinical workforces, modifying administration-set inventories and establishing new biomedical maintenance procedures. These switching costs create long replacement cycles and significant incumbent advantages.
Procurement has therefore become increasingly enterprise-oriented. Large integrated delivery networks frequently seek one standardized infusion architecture across multiple hospitals rather than purchasing pumps independently by facility. Standardization can simplify nursing training, centralize drug-library governance, reduce SKU complexity, increase purchasing leverage and allow infusion data to be aggregated across the enterprise.
From 2026 through 2035, competitive differentiation will increasingly center on the ability to deliver a reliable and secure medication-management platform rather than simply a pump. Suppliers that combine accurate infusion delivery with EHR interoperability, intuitive programming, clinically effective alarm management, strong cybersecurity, dependable administration-set supply, fleet analytics and responsive technical support will have an advantage in large U.S. hospital tenders.
Key Market Drivers: What’s Fueling the U.S. Volumetric Infusion Pumps Market Boom?
The first structural driver is the enormous installed base of U.S. hospital infusion infrastructure. More than 900,000 staffed hospital beds require access to intravenous therapy, while intensive care patients frequently receive several simultaneous continuous infusions. Because pumps are moved between departments, subjected to continuous cleaning, transported with patients and operated for thousands of hours, fleet replacement is unavoidable. Replacement demand alone establishes a durable baseline even in years when hospital admissions grow slowly.
A second driver is the expanding complexity of intravenous pharmacotherapy. Modern hospitalized patients increasingly receive combinations of antibiotics, anticoagulants, vasoactive drugs, sedation, biologics, hydration fluids, electrolytes and nutritional therapy. Oncology and hematology patients may receive multiple sequential or concurrent infusions, while critically ill patients can require numerous channels simultaneously. This increases demand not only for pumps but for modular systems capable of managing multiple therapies without excessive bedside clutter.
The third driver is medication safety. Programming an infusion rate incorrectly can cause clinically significant overinfusion, underinfusion or interruption of treatment. U.S. hospitals consequently place high value on dose-error reduction systems, customized drug libraries, hard and soft dosing limits, standardized concentrations and pump-EHR interoperability. Infusion safety has therefore evolved from an optional premium feature into a core procurement criterion.
Interoperability represents a fourth major growth catalyst. Bidirectional communication between smart pumps and hospital electronic health records can allow ordered infusion parameters to populate automatically at the bedside after patient and medication verification. Infusion information can then flow back into the clinical record. This removes manual transcription steps and has the potential to reduce programming errors while improving documentation completeness. Hospitals investing heavily in digital clinical infrastructure increasingly expect the infusion fleet to participate in this connected workflow.
The fifth driver is the replacement of legacy pump platforms. U.S. hospitals often operate infusion systems for many years, creating periodic waves of large capital replacement. Regulatory remediation, discontinued products, unsupported software, component scarcity, cybersecurity concerns and evolving interoperability requirements can accelerate replacement before mechanical end-of-life. A single enterprise conversion can involve several thousand pump channels and represent a major multiyear contract.
A sixth driver is hospital labor economics. Nurse shortages have increased the value of technologies capable of reducing manual programming, simplifying setup, shortening troubleshooting time and improving documentation. Procurement committees increasingly examine how many nursing steps an infusion workflow requires rather than focusing solely on device acquisition cost. A system that saves modest time per infusion can generate meaningful labor benefits when multiplied across millions of annual medication administrations.
Recurring disposable economics are equally important. Volumetric infusion systems rely on administration sets that generate repeat utilization throughout the life of the installed fleet. Consequently, suppliers can structure contracts using combinations of pump pricing, disposable commitments, software agreements and service terms. Health systems increasingly model the total cost of ownership over several years, including infusion sets, preventive maintenance, battery replacement, software, connectivity infrastructure and staff training.
Finally, chronic disease and specialty-drug treatment continue to increase infusion intensity. Cancer, serious infections, gastrointestinal disease, immune disorders and complex surgical recovery support ongoing IV therapy demand. While compact ambulatory pumps dominate many home-based treatments, volumetric pumps remain central to hospitals and outpatient infusion departments that require high throughput, flexible fluid delivery and sophisticated medication safety controls.
Innovation in Focus: How Manufacturers Are Raising the Bar?
Innovation in volumetric infusion pumps is increasingly software-led. Mechanical flow performance remains fundamental, but hospital buyers now expect an infusion system to become part of the digital medication-management architecture. Manufacturers are consequently investing heavily in connectivity, cybersecurity, user-interface design, data analytics and automated medication programming.
Smart drug libraries are a central innovation area. Hospitals can build standardized dosing limits by medication, concentration, patient population and care area. When clinicians attempt to program values outside predefined limits, the system can provide an alert or prevent initiation depending on the rule. More sophisticated platforms also provide data showing how often limits are bypassed, which drugs generate the largest number of alerts and where programming behavior may require clinical review.
EHR interoperability is moving the market toward closed-loop medication administration. A nurse can scan the patient, medication and pump channel, allowing verified parameters from the electronic order to populate the pump. This reduces manual data entry and strengthens alignment between physician orders, pharmacy preparation, nursing administration and documentation. For large health systems, interoperability can become a decisive factor in competitive tenders because the economic benefit is distributed across clinical quality, nursing efficiency and documentation integrity.
User-interface innovation is another competitive battleground. Infusion pumps are operated by nurses under time pressure, including in emergency and critical-care environments. Manufacturers are therefore emphasizing larger displays, clearer therapy selection, fewer programming steps, more intuitive alarm descriptions and visual separation of multiple channels. Human-factors engineering has become an important regulatory and commercial requirement because sophisticated software provides limited value if clinicians struggle to operate it safely.
Wireless fleet management is also developing rapidly. Connected pumps can provide information on device location, software status, utilization and maintenance requirements. Biomedical engineering departments can use these capabilities to identify underutilized equipment, reduce unnecessary fleet purchases and improve preventive maintenance planning. At enterprise scale, even small improvements in utilization can materially affect capital requirements.
Cybersecurity is becoming a permanent purchasing requirement. A connected infusion pump represents an endpoint within a hospital network and must be managed accordingly. Health systems increasingly assess software architecture, authentication, encryption, vulnerability management, update mechanisms and manufacturer response processes during procurement. Cybersecurity performance can influence product selection even when two platforms provide comparable infusion accuracy.
Manufacturers are also redesigning administration sets, pumping mechanisms and occlusion-management systems to improve flow consistency and reduce setup errors. Pump-set interaction is commercially critical because a safety issue involving the disposable can affect the entire installed platform. Reliable supply of compatible administration sets has therefore become a strategic component of vendor qualification.
The next innovation cycle will increasingly involve predictive analytics. Aggregated infusion data can potentially identify frequently overridden alerts, pump utilization patterns, recurring workflow delays and unusual infusion practices. Health systems are interested in turning the pump from a passive delivery device into a source of medication-use intelligence that supports pharmacy governance, quality improvement and clinical operations.
Segmentation Insights
The U.S. Volumetric Infusion Pumps Market is segmented on the basis of pump configuration, application, end user, technology type and region.
By Pump Configuration
Standalone Single-Channel Volumetric Pumps
Standalone single-channel pumps remain important in general hospital environments where one primary infusion is required and flexibility is prioritized. These systems can be easier to transport and maintain than complex modular architectures. Demand is strongest among community hospitals, outpatient departments and clinical environments where simultaneous multi-drug infusion is less frequent.
Growth in this category will remain moderate because large tertiary systems increasingly favor modular architectures, yet single-channel products retain an important role in transport, step-down care and facilities seeking lower acquisition complexity.
Modular Multi-Channel Infusion Systems
Modular multi-channel systems represent the highest-value configuration within the U.S. hospital market. They allow several pump modules to operate through a common controller or integrated bedside architecture, making them particularly valuable in intensive care, anesthesia, emergency medicine and complex inpatient therapy.
These platforms offer substantial strategic advantages to manufacturers because one installed control architecture can drive recurring purchases of additional channels, administration sets, software and services. Hospitals also benefit from standardized user interfaces and centralized drug-library management.
Large-Volume Smart Pumps
Smart large-volume pumps incorporating dose-error reduction software represent the market’s core growth segment. These products combine volumetric delivery with drug libraries, medication limits, event logging and connectivity. Smart capability has increasingly become the default requirement for major U.S. acute-care procurement rather than a premium optional specification.
Replacement activity is expected to favor platforms that provide strong drug-library compliance, efficient software deployment and integration with major hospital information systems.
Transport-Capable Volumetric Pumps
Transport-capable systems address movement between emergency departments, imaging departments, operating rooms, intensive care and inpatient floors. Battery endurance, physical durability, mounting compatibility and alarm visibility are important purchasing variables.
Demand is supported by the increasing complexity of hospital patient movement. Critically ill patients frequently require uninterrupted infusion during intrahospital transport, making battery reliability and rapid transition between mobile and fixed workflows clinically important.
Specialty and High-Acuity Volumetric Systems
Specialty systems configured for neonatal, pediatric, oncology, blood-product or other high-acuity applications represent a smaller but clinically sensitive segment. Flow performance at lower rates, precise occlusion detection and specialty drug-library configurations can be particularly important.
Children’s hospitals and academic centers generally impose more demanding validation requirements because comparatively small deviations in infused volume can have greater clinical consequences in neonatal and pediatric populations.
By Application
IV Fluids and Hydration
Hydration and maintenance-fluid delivery represents one of the broadest volumetric infusion applications. Saline, electrolyte solutions and other fluids are administered across emergency departments, surgical units and inpatient wards.
Although these therapies may carry lower per-infusion pharmaceutical value than oncology or critical-care medications, their extremely high frequency creates substantial pump utilization and administration-set demand.
Antibiotics and Anti-Infective Therapy
Anti-infective therapy is a major application because severe infections frequently require repeated or continuous IV administration. The approximately 1.7 million annual U.S. adult sepsis cases illustrate the scale of acute infection management supported by infusion technology.
Hospitals increasingly integrate standardized antibiotic concentrations and infusion durations into smart-pump drug libraries. Extended and continuous antimicrobial infusions are also reinforcing the importance of accurate programmable delivery.
Oncology and Chemotherapy
Oncology represents one of the highest-value application environments. More than two million new U.S. cancer diagnoses annually support substantial demand for chemotherapy, immunotherapy, hydration, supportive drugs, antiemetics and related intravenous treatments.
Cancer centers value pumps that support complex treatment protocols, reliable documentation and integration with oncology medication workflows. Expansion of hospital outpatient infusion centers is expected to strengthen this segment through 2035.
Parenteral Nutrition
Parenteral nutrition requires controlled delivery of nutrient solutions over extended periods and therefore depends on reliable infusion technology. Utilization is concentrated among patients with gastrointestinal failure, major surgery, critical illness and neonatal conditions.
Accuracy, alarm performance and long-duration operational reliability are particularly important. Academic medical centers, neonatal units and tertiary hospitals represent major users.
Critical Care, Blood Products and Other High-Acuity Therapy
Critical-care infusion includes vasoactive medications, sedatives, anticoagulants, blood products and multiple other drugs requiring precise delivery. ICU patients often require several simultaneous infusion channels, making this application a major driver of modular pump demand.
The clinical consequences of interruption or dosing error can be substantial, meaning hospitals often prioritize redundancy, alarm management and interoperability over acquisition price in these environments.
By End User
Hospitals and Integrated Health Systems
Hospitals represent the dominant end-user segment and account for the majority of installed volumetric pump capacity. Large systems operate thousands of infusion channels and frequently negotiate enterprise contracts covering equipment, disposables, software and service.
Health-system consolidation is strengthening centralized procurement. Enterprise standardization can significantly increase the competitive value of winning a single integrated delivery network because platform decisions may extend across numerous hospitals and outpatient sites.
Academic Medical Centers and Tertiary Referral Hospitals
Academic centers are influential early adopters because they manage complex clinical cases and frequently evaluate advanced interoperability, pediatric functionality and high-acuity workflow requirements.
These hospitals can influence broader adoption through clinical training, published medication-safety programs and reference-site relationships with manufacturers.
Outpatient Infusion and Oncology Centers
Hospital outpatient departments and dedicated infusion centers are becoming increasingly important as cancer, biologic and specialty-drug administration shifts away from inpatient hospitalization.
These sites prioritize throughput, chair utilization, predictable workflow and integration with pharmacy scheduling. The ability to operate a standardized platform across both hospital and outpatient settings can strengthen enterprise procurement economics.
Ambulatory Surgery Centers and Specialty Clinics
Volumetric pumps are used selectively in ambulatory surgery and specialty clinics for hydration, anesthesia-related therapy, antibiotics and procedural medications. These facilities generally require fewer channels and place greater emphasis on compact design, acquisition economics and ease of maintenance.
Growth will be supported by continued migration of appropriate procedures away from inpatient settings.
Home Infusion and Alternate-Site Providers
Home infusion represents a smaller direct market for traditional large-volume pumps because ambulatory and elastomeric devices are frequently preferred. Nevertheless, selected long-duration therapies and complex patients can require electronic volumetric systems.
The broader expansion of U.S. home infusion reinforces demand for portable technologies, remote support and simplified programming, influencing how manufacturers design future volumetric platforms.
By Technology Type
Conventional Electronic Volumetric Pumps
Conventional programmable pumps without extensive connected functionality remain present across smaller and legacy hospital fleets. Their lower software complexity can reduce upfront costs, but they are increasingly disadvantaged where enterprise buyers require connectivity and centralized safety management.
Their market share is expected to decline progressively through 2035.
Smart Pumps with Dose-Error Reduction Systems
Smart pumps incorporating dose-error reduction software represent the largest technology category. Drug libraries allow hospitals to establish medication-specific limits and standardized concentrations.
The economic value extends beyond error prevention because pump data can also support pharmacy review, clinical governance and standardization across hospitals.
Wireless Connected Infusion Pumps
Wireless connectivity allows pumps to receive software updates, drug-library revisions and configuration changes without extensive manual intervention. Connected platforms can also transmit status and utilization data.
This is increasingly important for health systems operating several thousand devices across multiple campuses.
EHR-Interoperable Infusion Platforms
EHR-interoperable pumps are expected to represent the fastest-growing technology segment. Auto-programming can transfer verified infusion parameters from the electronic order to the pump, while auto-documentation returns administration data to the clinical record.
This architecture addresses two major hospital priorities simultaneously: medication safety and nursing workflow efficiency.
Advanced Analytics and Fleet-Management Platforms
Analytics platforms are emerging as a strategic layer around the installed pump base. They can show device utilization, alarm frequency, drug-library alerts, compliance levels and operational patterns.
Hospitals will increasingly use these data to determine optimal fleet size, identify training opportunities and improve medication administration governance.
Regional Insights: Where the Market Is Growing Fastest
The U.S. Volumetric Infusion Pumps Market is geographically segmented into the South, Northeast, West and Midwest. Regional demand differs according to hospital-bed density, population growth, cancer and chronic-disease burden, concentration of large integrated delivery networks, academic medical-center presence, capital budgets and speed of smart-pump interoperability adoption.
The South represents the largest regional market in 2025 at approximately USD 0.20 billion. The Northeast accounts for approximately USD 0.14 billion, followed by the West at approximately USD 0.12 billion and the Midwest at approximately USD 0.09 billion. The West is expected to produce the fastest percentage growth through 2035, while the South should remain the largest absolute revenue opportunity.
South
The South represents the largest U.S. volumetric infusion pump opportunity because it combines the country’s strongest population growth with extensive hospital construction, large integrated delivery networks and substantial chronic-disease burden. The regional market is estimated at approximately USD 0.20 billion in 2025 and could approach USD 0.47 billion by 2035.
The region includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia and the District of Columbia.
Texas is the most commercially important Southern state. Houston, Dallas-Fort Worth, Austin and San Antonio contain major tertiary hospitals, cancer centers and expanding health systems. Large hospital networks can generate enterprise procurement opportunities involving thousands of infusion channels and substantial recurring administration-set demand. Rapid population growth also continues to support hospital capacity expansion.
Florida is another major market because of its large and aging population, extensive hospital footprint and significant oncology and chronic-disease treatment demand. Health systems in Miami, Tampa, Orlando, Jacksonville and South Florida operate substantial infusion fleets across both inpatient hospitals and outpatient oncology programs.
North Carolina combines rapid population growth with nationally recognized academic and tertiary-care institutions. Charlotte, Raleigh-Durham and the broader Research Triangle support advanced hospital IT adoption, making the state particularly relevant for interoperable smart-pump deployments.
Georgia is driven by Atlanta’s large hospital networks and regional referral role. Continued metropolitan growth supports rising inpatient, oncology and emergency-care capacity.
Virginia and Maryland benefit from sophisticated provider infrastructure surrounding Washington, D.C., Baltimore and Northern Virginia. These markets have comparatively high digital maturity and strong adoption potential for enterprise medication-management platforms.
Tennessee contains major hospital systems and hospital-management organizations, giving procurement decisions made within the state influence beyond its population size. Nashville is particularly important as a center for healthcare corporate decision-making.
Kentucky, West Virginia, Mississippi, Alabama, Louisiana, Arkansas and Oklahoma present a different commercial profile. Large tertiary referral centers remain attractive for premium connected systems, while rural and smaller hospitals place greater emphasis on fleet reliability, service coverage and total ownership cost. Vendors capable of supporting both large metropolitan networks and geographically dispersed community facilities can build durable positions.
The South’s growth through 2035 will be driven by hospital expansion, oncology infusion growth, rising inpatient complexity, health-system consolidation and replacement of legacy fleets. The region is likely to remain the country’s largest source of new pump placements and administration-set consumption.
West
The West represented approximately USD 0.12 billion in 2025 and is projected to approach USD 0.33 billion by 2035, making it the fastest-growing region under the forecast model.
The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.
California dominates the regional market because of its population scale, extensive hospital infrastructure, numerous academic centers and large integrated provider organizations. Los Angeles, San Diego, San Francisco, Sacramento and the Bay Area contain sophisticated health systems that frequently prioritize interoperability, medication safety analytics and enterprise digital architecture.
California is strategically important because major procurement programs can involve complex integration with EHR platforms, pharmacy systems, wireless networks and cybersecurity frameworks. Vendors that succeed in these environments gain high-value reference sites for national expansion.
Washington and Oregon demonstrate strong adoption of integrated care models and digitally enabled hospital operations. Seattle and Portland contain large systems capable of evaluating smart infusion platforms through enterprise-level clinical and IT governance.
Arizona and Nevada are high-growth markets because of rapid population expansion and increasing hospital capacity. Phoenix, Tucson and Las Vegas continue to attract healthcare investment as populations rise and age.
Colorado and Utah combine comparatively strong hospital-system integration with growing metropolitan populations. Denver and Salt Lake City are especially relevant for advanced acute-care and specialty treatment programs.
Idaho, Montana, Wyoming, New Mexico and Alaska are smaller markets but have distinctive needs related to geographic dispersion. Equipment reliability, technical service reach, standardized training and remote fleet-management capabilities can be particularly valuable where hospitals are separated by long distances.
Hawaii represents a relatively small but concentrated market where logistics and supply continuity can influence purchasing decisions. Reliable availability of pump-specific administration sets is particularly important for island healthcare systems.
The West is likely to gain national share through 2035 because its leading health systems are receptive to digital medication-management technologies. Interoperability, analytics, cloud-connected fleet management and cybersecurity performance should therefore carry disproportionate competitive weight.
Northeast
The Northeast accounted for approximately USD 0.14 billion in 2025 and is projected to reach roughly USD 0.31 billion by 2035.
The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York and Pennsylvania.
New York is the largest state-level market in the Northeast. New York City alone contains numerous high-acuity academic and tertiary hospitals, while large systems extend throughout Long Island, Westchester, the Hudson Valley and upstate metropolitan areas. Hospital density and clinical complexity support substantial volumetric pump utilization.
Pennsylvania represents another major market through Philadelphia, Pittsburgh and large statewide health systems. The state has substantial inpatient, oncology and academic medical activity, supporting both fleet replacements and connected-pump upgrades.
Massachusetts is strategically important despite its smaller population because Boston contains one of the world’s most concentrated academic healthcare ecosystems. Institutions in the state frequently influence medication-safety practices, digital clinical workflows and early technology evaluation.
New Jersey benefits from dense population, major pharmaceutical and healthcare industries and proximity to New York and Philadelphia. Hospital networks across northern and central New Jersey represent valuable enterprise procurement targets.
Connecticut has a comparatively concentrated health-system structure, creating opportunities for standardized regional pump deployments. Major systems can rapidly extend technology decisions across multiple facilities.
Maine, New Hampshire, Vermont and Rhode Island are smaller revenue markets but retain importance for regional hospital networks. Procurement in these states tends to emphasize reliability, service responsiveness and the ability to standardize technology across smaller facilities connected to larger tertiary hubs.
The Northeast is unlikely to match the population-driven expansion of the South or West, but it should remain one of the highest-value regions for sophisticated systems. The concentration of academic medical centers and high-acuity hospitals supports strong demand for EHR interoperability, advanced drug-library governance and analytics.
Midwest
The Midwest represented approximately USD 0.09 billion in 2025 and is projected to reach approximately USD 0.22 billion by 2035.
The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota.
Illinois is led by Chicago’s large academic and community hospital ecosystem. Large multi-hospital organizations create attractive enterprise replacement opportunities, particularly when older infusion platforms reach the end of supported life.
Ohio represents a significant market because of its concentration of major hospital systems and nationally recognized tertiary-care institutions. Cleveland, Columbus and Cincinnati provide substantial demand across critical care, oncology and surgical infusion workflows.
Michigan has a large hospital base centered around Detroit, Ann Arbor and other population centers. Health-system consolidation has increased the strategic value of enterprise contracts covering multiple hospitals.
Minnesota is particularly influential because of its medical-device heritage and sophisticated health-system environment. Minneapolis–St. Paul and Rochester support high-acuity care and strong clinical engineering capabilities, making the state relevant for advanced infusion technology evaluation.
Indiana and Wisconsin provide stable demand from large integrated hospital networks, while Missouri benefits from major health systems in St. Louis and Kansas City.
Iowa, Kansas and Nebraska contain a combination of tertiary referral facilities and rural hospitals. Regional referral patterns increase the importance of interoperability and standardization when patients move between smaller community sites and urban centers.
North Dakota and South Dakota represent smaller markets, but geographic dispersion makes durable equipment, remote technical support and effective fleet management especially valuable.
The Midwest should provide steady replacement demand through 2035. Manufacturers that offer dependable service, strong contracting economics and robust interoperability are likely to perform better than suppliers competing primarily on hardware specifications.
Key Market Players
The U.S. Volumetric Infusion Pumps Competitive Landscape is concentrated around a relatively small number of large-volume pump platform manufacturers, but the wider ecosystem includes administration-set suppliers, infusion-service organizations, distributors, clinical engineering companies and digital medication-management partners.
The most strategically important competitive positions are held by manufacturers with large installed hospital fleets because recurring administration-set purchases, service agreements and software relationships create substantial switching costs. Market competition therefore operates on an account-life-cycle basis rather than simply on individual pump sales.
Major and relevant participants in the U.S. volumetric infusion pump and associated infusion-management ecosystem include:
Becton, Dickinson and Company
Baxter International Inc.
ICU Medical, Inc.
Fresenius Kabi
B. Braun Medical Inc.
Terumo Corporation
Mindray
Zyno Medical
Eitan Medical
Moog Inc.
Nipro Corporation
Avanos Medical
CODAN Companies
Vygon
Medline Industries
Cardinal Health
McKesson Medical-Surgical
Owens & Minor
InfuSystem Holdings
Agiliti
TRIMEDX
PartsSource
Epic Systems
Oracle Health
At the primary pump-platform level, BD, Baxter, ICU Medical, Fresenius Kabi and B. Braun represent the most strategically significant competitors. Their positions are supported by established hospital relationships, infusion-system portfolios, proprietary or compatible administration sets, drug-library capabilities and service infrastructure.
BD’s Alaris platform has a particularly large installed footprint and benefits from modularity across large-volume, syringe and other infusion functions. Baxter is pursuing a new competitive cycle around its Novum IQ architecture. ICU Medical’s Plum platform has a longstanding acute-care presence and is being expanded through newer pump technology. Fresenius Kabi’s Ivenix platform differentiates through modern user-interface and connected-infusion architecture. B. Braun competes through its Space infusion portfolio and broader infusion-therapy capabilities.
Competitive intensity should remain high through 2035 because pump conversions are infrequent but commercially significant. Winning an enterprise tender can produce years of recurring disposable revenue, while losing an installed fleet can materially weaken a supplier’s regional share.
Market share will increasingly be determined by six factors: safety performance, regulatory execution, EHR interoperability, administration-set supply reliability, cybersecurity and total enterprise economics. Hospitals are also expected to scrutinize manufacturer response speed when software or device issues emerge.
Recent Developments
The U.S. volumetric infusion pump market has entered an important replacement and technology-refresh cycle.
In July 2023, the updated BD Alaris Infusion System received U.S. FDA 510(k) clearance, allowing BD to resume full commercial operations for an updated platform that included large-volume pump hardware, software, cybersecurity improvements and interoperability functionality. The development was commercially significant because Alaris has a substantial existing U.S. installed base.
In March 2024, Baxter’s Novum IQ Large Volume Pump received FDA 510(k) clearance. The platform represents Baxter’s strategic move toward a new generation of connected large-volume infusion technology and provides the company with an important architecture for future hospital fleet conversions.
During 2024, Fresenius Kabi implemented software corrections involving the Ivenix Large Volume Pump. The events reinforced an important market reality: modern infusion pumps are software-intensive medical devices, and software quality, update infrastructure and cybersecurity management are increasingly central to lifecycle performance.
In April 2025, ICU Medical received FDA 510(k) clearance for the Plum Duo Precision IV Pump. This introduced another important competitive option into the U.S. large-volume infusion landscape and strengthens the prospect of more active enterprise fleet competition during the forecast period.
The market has also experienced prominent safety corrections involving newly introduced platforms. Baxter issued corrections involving Novum IQ Large Volume Pumps during 2025 relating to potential infusion-performance and software issues. These events highlight the demanding safety environment surrounding volumetric infusion and the consequences manufacturers face when a pump issue potentially affects high-risk medications or critically ill patients.
Fresenius Kabi has similarly addressed Ivenix software, administration-set and device-performance issues through field corrections and recalls. Developments extending into 2026 demonstrate why hospitals increasingly evaluate not only initial product specifications but the manufacturer’s entire post-market surveillance, software-update and technical-response capability.
These events are unlikely to reduce long-term demand for advanced pumps. Instead, they are likely to raise the standard required for adoption. Hospital value-analysis committees will place greater emphasis on real-world reliability, human-factors validation, cybersecurity, software lifecycle management and responsiveness to field issues.
Another important development is the growing expectation for bidirectional smart-pump interoperability. Medication-safety organizations increasingly encourage hospitals to move toward integration that supports auto-programming and auto-documentation. As more health systems modernize EHR environments, interoperability will become a competitive requirement rather than a differentiating feature limited to leading academic hospitals.
The commercial consequence is a transition toward larger, more complex procurement programs. Future tenders will increasingly bundle pumps, software, drug libraries, interfaces, data analytics, cybersecurity commitments, administration sets, biomedical support and staff training into multiyear contracts.
Conclusion
The U.S. Volumetric Infusion Pumps Market Size & Share is positioned to increase from approximately USD 0.55 billion in 2025 to USD 1.33 billion by 2035, representing a projected 9.20% CAGR during 2026–2035.
The market’s expansion will be supported by the scale of U.S. acute-care infrastructure, replacement of aging infusion fleets, increasing complexity of intravenous therapy, growth in oncology and critical-care infusion, stronger medication-safety requirements and the continuing shift toward connected medication administration.
The most important structural change is the evolution of the volumetric pump from a stand-alone device into a component of the hospital’s digital medication-management infrastructure. Buyers increasingly require drug-error reduction software, EHR connectivity, cybersecurity, centralized configuration and analytics in addition to dependable fluid delivery.
This transition materially changes competition. Manufacturers will increasingly compete on the performance of an integrated ecosystem consisting of pump hardware, administration sets, software, interoperability, service and clinical workflow support. Because installed platforms can remain in hospitals for many years, enterprise conversions represent high-value strategic wins.
Hospitals will also evaluate total lifecycle economics more rigorously. Acquisition cost alone provides an incomplete comparison. Decision-makers need to understand disposable utilization, software expense, interface implementation, clinical training, biomedical engineering requirements, battery replacement, fleet utilization, maintenance, downtime and the potential productivity value of automated workflows.
Geographically, the South will remain the largest opportunity, driven by Texas, Florida, North Carolina, Georgia, Virginia and other rapidly growing healthcare markets. The West is expected to achieve the fastest growth, supported by California and digitally advanced health systems across Washington, Colorado, Arizona and Utah. The Northeast will remain a premium, high-acuity market, while the Midwest will provide a durable base of replacement-driven hospital demand.
At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, North Carolina, Massachusetts, New Jersey, Georgia, Michigan, Washington, Arizona, Virginia, Tennessee, Minnesota and Colorado should remain especially important for manufacturers and investors evaluating commercial deployment.
For clients assessing this market, the critical issue is therefore not simply how many volumetric pumps U.S. hospitals will purchase. The more valuable questions concern which installed fleets are approaching replacement, which health systems are moving toward EHR interoperability, which vendors can protect recurring administration-set revenue, how regulatory events could shift competitive share, and which regional hospital networks represent the highest-probability enterprise conversion opportunities.
The companies best positioned through 2035 will be those that combine dependable infusion delivery with medication safety, intuitive clinical workflow, cybersecurity, interoperability, supply continuity and demonstrable hospital economics. In that environment, the U.S. volumetric infusion pump is becoming less of a commodity capital device and more of a long-term digital medication-management platform.
TABLE OF CONTENT
1. U.S. Volumetric Infusion Pumps Market: Market Introduction & Context
1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Installed-Base Estimation & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Volumetric Infusion Pump Manufacturers
1.6.2. Infusion Set and Disposable Manufacturers
1.6.3. Electronic Component, Sensor and Pump Module Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers and Specialty Hospitals
1.6.6. Outpatient Infusion and Oncology Centers
1.6.7. Ambulatory Surgery Centers and Specialty Clinics
1.6.8. Home and Alternate-Site Infusion Providers
1.6.9. Group Purchasing Organizations and Medical Distributors
1.6.10. Hospital Pharmacy and Medication Safety Teams
1.6.11. Clinical Engineering and Biomedical Service Providers
1.6.12. EHR, Interoperability and Healthcare IT Vendors
1.6.13. FDA, CMS and Other Regulatory Stakeholders
What this section provides: This section defines the U.S. volumetric infusion pumps market boundary, study scope, sizing methodology, assumptions, installed-base framework and stakeholder ecosystem so clients understand precisely how the market is measured and validated.
2. U.S. Volumetric Infusion Pumps Market: Executive Summary
2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Installed Pump Fleet Assessment
2.8. Smart and Connected Pump Adoption Snapshot
2.9. Hospital Fleet Replacement Opportunity
2.10. High-Growth Opportunity Areas
2.11. Leading Regional Opportunity Pockets
2.12. Key Competitive and Procurement Takeaways
What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical development, installed-base dynamics, smart-pump adoption, regional opportunities, competitive intensity and priority growth areas.
3. U.S. Volumetric Infusion Pumps Market: Market Dynamics & Outlook
3.1. Drivers and Their Impact Analysis
3.1.1. Large U.S. Hospital and Acute-Care Infrastructure Base
3.1.2. Increasing Volume and Complexity of Intravenous Drug Administration
3.1.3. Rising Need for Medication Error Reduction and Infusion Safety
3.1.4. Replacement of Aging Large-Volume Infusion Pump Fleets
3.1.5. Growing Adoption of Smart Pumps with Dose-Error Reduction Systems
3.1.6. Expansion of Bidirectional EHR-Pump Interoperability
3.1.7. Rising Oncology, Critical Care and Anti-Infective Infusion Demand
3.1.8. Hospital Workforce Shortages and Nursing Workflow Optimization
3.1.9. Growing Enterprise Standardization Across Integrated Delivery Networks
3.1.10. Recurring Administration Set and Disposable Revenue Economics
3.2. Restraints and Their Impact Analysis
3.2.1. High Initial Fleet Conversion Costs
3.2.2. Long Hospital Capital Equipment Replacement Cycles
3.2.3. Infusion Pump Recalls and Product Safety Concerns
3.2.4. Software Reliability and Cybersecurity Risk
3.2.5. Proprietary Administration Set and Consumable Cost Burden
3.2.6. Complex EHR Integration and Implementation Requirements
3.2.7. Nursing Training and Workflow Transition Challenges
3.2.8. Hospital Capital Budget Constraints
3.3. Opportunities and Their Impact Analysis
3.3.1. Enterprise Smart Pump Fleet Modernization
3.3.2. Bidirectional Auto-Programming and Auto-Documentation
3.3.3. Advanced Dose-Error Reduction Software
3.3.4. Cloud-Connected Infusion Management
3.3.5. Infusion Analytics and Drug-Library Optimization
3.3.6. Predictive Fleet Management and Asset Utilization
3.3.7. Expansion of Outpatient Oncology Infusion
3.3.8. Connected Medication Administration Ecosystems
3.3.9. Cybersecurity-Driven Pump Replacement
3.3.10. Emerging AI-Assisted Infusion Workflow Analytics
3.4. Challenges and Their Impact Analysis
3.4.1. Alarm Fatigue and Alert Override Behavior
3.4.2. Drug Library Standardization Across Multi-Hospital Networks
3.4.3. Administration Set Supply Continuity
3.4.4. Biomedical Engineering Maintenance Burden
3.4.5. Integration with Multiple EHR and Pharmacy Platforms
3.4.6. Managing Legacy and Next-Generation Pumps Simultaneously
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Nursing Productivity Impact Analysis
3.8. Medication Safety Economics Analysis
3.9. Hospital Capital Procurement Behavior Analysis
3.10. Volumetric Pump Replacement Cycle Analysis
3.11. Installed Base versus New Placement Opportunity Analysis
What this section provides: This section evaluates the clinical, economic, technological and operational forces shaping volumetric infusion pump demand and helps clients identify growth catalysts, adoption barriers and execution risks.
4. U.S. Volumetric Infusion Pumps Market: Market Environment & Industry Analysis
4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Volumetric Infusion Pump Pricing Trend Analysis, 2025–2035
4.4. Administration Set and Disposable Pricing Analysis
4.5. Value Chain Analysis
4.6. Supply Chain and Component Availability Analysis
4.7. Impact of Smart Hospital Digitalization
4.8. Drug Library and Dose-Error Reduction Ecosystem
4.9. EHR and Pharmacy System Interoperability Landscape
4.10. FDA Regulatory Framework Analysis
4.11. FDA Infusion Pump Safety and Recall Environment
4.12. Medical Device Cybersecurity Requirements
4.13. CMS Reimbursement and Hospital Payment Environment
4.14. Import/Export Restrictions & Tariff Impact
4.15. Government Healthcare and Medication Safety Initiatives
4.16. Impact of Escalating Geopolitical and Supply Chain Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. Total Cost of Ownership Analysis
4.19. Pump Hardware versus Disposable Revenue Economics
What this section provides: This section gives clients a comprehensive view of regulation, pricing, interoperability, cybersecurity, reimbursement, supply chain, technology adoption and the total-cost economics influencing U.S. volumetric infusion pump purchasing.
5. U.S. Volumetric Infusion Pumps Market – By Pump Configuration
5.1. Overview
5.1.1. Segment Share Analysis, By Pump Configuration, 2025 & 2035 (%)
5.1.2. Standalone Single-Channel Volumetric Pumps
5.1.3. Modular Multi-Channel Volumetric Infusion Systems
5.1.4. Smart Large-Volume Infusion Pumps
5.1.5. Transport-Capable Volumetric Infusion Pumps
5.1.6. Specialty and High-Acuity Volumetric Infusion Systems
What this section provides: This section identifies which volumetric pump configurations generate the greatest installed-base demand, recurring revenue and replacement opportunity through 2035.
6. U.S. Volumetric Infusion Pumps Market – By Application
6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. IV Fluids and Hydration Therapy
6.1.3. Antibiotics and Anti-Infective Therapy
6.1.4. Oncology and Chemotherapy
6.1.5. Parenteral Nutrition
6.1.6. Critical Care and Vasoactive Drug Administration
6.1.7. Blood and Blood Product Administration
6.1.8. Perioperative and Anesthesia-Related Infusion
6.1.9. Other Specialty Infusion Applications
What this section provides: This section evaluates volumetric pump demand by clinical application and identifies therapy areas creating the highest pump utilization, infusion-set consumption and workflow requirements.
7. U.S. Volumetric Infusion Pumps Market – By End User
7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.3. Academic Medical Centers and Tertiary Hospitals
7.1.4. Outpatient Infusion and Oncology Centers
7.1.5. Ambulatory Surgery Centers
7.1.6. Specialty Clinics
7.1.7. Home Infusion and Alternate-Site Care Providers
What this section provides: This section identifies which U.S. care settings are expected to drive pump placements, fleet replacement, recurring disposable demand and adoption of connected infusion technology.
8. U.S. Volumetric Infusion Pumps Market – By Technology Type
8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Conventional Electronic Volumetric Infusion Pumps
8.1.3. Smart Pumps with Dose-Error Reduction Systems
8.1.4. Wireless Connected Infusion Pumps
8.1.5. EHR-Interoperable Volumetric Infusion Platforms
8.1.6. Advanced Analytics and Fleet-Management Enabled Platforms
What this section provides: This section evaluates the transition from conventional electronic pumps toward smart, connected, interoperable and analytics-enabled infusion platforms.
9. U.S. Volumetric Infusion Pumps Market: Procurement & Commercial Model Analysis
9.1. Overview of U.S. Infusion Pump Procurement
9.2. Direct Hospital and Health System Procurement
9.3. Integrated Delivery Network Enterprise Contracts
9.4. Group Purchasing Organization Influence
9.5. Distributor and Specialty Medical Supplier Channels
9.6. Capital Purchase Model
9.7. Rental and Equipment-as-a-Service Models
9.8. Disposable Commitment and Pump Placement Agreements
9.9. Software and Service Contract Models
9.10. Administration Set Contracting Dynamics
9.11. Hospital Request-for-Proposal and Tender Analysis
9.12. Vendor Standardization and Conversion Economics
9.13. Pump Fleet Replacement Decision Criteria
9.14. Biomedical Engineering Evaluation Criteria
9.15. Pharmacy and Medication Safety Committee Influence
9.16. Nursing and Clinical Workflow Evaluation
9.17. Healthcare IT and Cybersecurity Evaluation
9.18. Total Cost of Ownership Benchmarking
9.19. Contract Duration and Vendor Lock-In Analysis
What this section provides: This section explains how U.S. volumetric infusion pumps are evaluated, contracted, financed and standardized across hospitals and IDNs without treating procurement as an additional market segmentation.
10. U.S. Volumetric Infusion Pumps Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital Bed and Acute-Care Infrastructure Analysis
10.1.4. Regional Infusion Pump Installed-Base Analysis
10.1.5. Regional Smart Pump Penetration Analysis
10.1.6. Regional Fleet Replacement Opportunity
10.1.7. Regional Hospital Procurement and IDN Dynamics
10.1.8. Regional Oncology and Critical-Care Infusion Demand
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Pump Configuration, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Installed Base, Fleet Replacement and Procurement Dynamics
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035
10.2.9.6. California Installed Base and Procurement Dynamics
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035
10.2.10.6. Washington Installed Base and Procurement Dynamics
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035
10.2.11.6. Arizona Installed Base and Procurement Dynamics
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035
10.2.12.6. Colorado Installed Base and Procurement Dynamics
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035
10.2.13.6. Oregon Installed Base and Procurement Dynamics
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035
10.2.14.6. Utah Installed Base and Procurement Dynamics
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035
10.2.15.6. Nevada Installed Base and Procurement Dynamics
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035
10.2.16.6. New Mexico Installed Base and Procurement Dynamics
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035
10.2.17.6. Idaho Installed Base and Procurement Dynamics
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035
10.2.18.6. Montana Installed Base and Procurement Dynamics
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035
10.2.19.6. Wyoming Installed Base and Procurement Dynamics
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035
10.2.20.6. Alaska Installed Base and Procurement Dynamics
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Pump Configuration, 2021–2035
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035
10.2.21.6. Hawaii Installed Base and Procurement Dynamics
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035
10.3.4. Northeast Region Market Size and Forecast, By Pump Configuration, 2021–2035
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035
10.3.8. Northeast Region Installed Base, Fleet Replacement and Procurement Dynamics
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. Market Size and Forecast, By Pump Configuration
10.3.9.3. Market Size and Forecast, By Application
10.3.9.4. Market Size and Forecast, By End User
10.3.9.5. Market Size and Forecast, By Technology Type
10.3.9.6. Installed Base and Procurement Dynamics
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Market Size and Forecast, By Pump Configuration
10.3.10.3. Market Size and Forecast, By Application
10.3.10.4. Market Size and Forecast, By End User
10.3.10.5. Market Size and Forecast, By Technology Type
10.3.10.6. Installed Base and Procurement Dynamics
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. Market Size and Forecast, By Pump Configuration
10.3.11.3. Market Size and Forecast, By Application
10.3.11.4. Market Size and Forecast, By End User
10.3.11.5. Market Size and Forecast, By Technology Type
10.3.11.6. Installed Base and Procurement Dynamics
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Market Size and Forecast, By Pump Configuration
10.3.12.3. Market Size and Forecast, By Application
10.3.12.4. Market Size and Forecast, By End User
10.3.12.5. Market Size and Forecast, By Technology Type
10.3.12.6. Installed Base and Procurement Dynamics
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Market Size and Forecast, By Pump Configuration
10.3.13.3. Market Size and Forecast, By Application
10.3.13.4. Market Size and Forecast, By End User
10.3.13.5. Market Size and Forecast, By Technology Type
10.3.13.6. Installed Base and Procurement Dynamics
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Market Size and Forecast, By Pump Configuration
10.3.14.3. Market Size and Forecast, By Application
10.3.14.4. Market Size and Forecast, By End User
10.3.14.5. Market Size and Forecast, By Technology Type
10.3.14.6. Installed Base and Procurement Dynamics
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Market Size and Forecast, By Pump Configuration
10.3.15.3. Market Size and Forecast, By Application
10.3.15.4. Market Size and Forecast, By End User
10.3.15.5. Market Size and Forecast, By Technology Type
10.3.15.6. Installed Base and Procurement Dynamics
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. Market Size and Forecast, By Pump Configuration
10.3.16.3. Market Size and Forecast, By Application
10.3.16.4. Market Size and Forecast, By End User
10.3.16.5. Market Size and Forecast, By Technology Type
10.3.16.6. Installed Base and Procurement Dynamics
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Market Size and Forecast, By Pump Configuration
10.3.17.3. Market Size and Forecast, By Application
10.3.17.4. Market Size and Forecast, By End User
10.3.17.5. Market Size and Forecast, By Technology Type
10.3.17.6. Installed Base and Procurement Dynamics
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Market Size and Forecast, By Pump Configuration
10.3.18.3. Market Size and Forecast, By Application
10.3.18.4. Market Size and Forecast, By End User
10.3.18.5. Market Size and Forecast, By Technology Type
10.3.18.6. Installed Base and Procurement Dynamics
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035
10.4.4. South Region Market Size and Forecast, By Pump Configuration, 2021–2035
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035
10.4.8. South Region Installed Base, Fleet Replacement and Procurement Dynamics
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Market Size and Forecast, By Pump Configuration
10.4.9.3. Market Size and Forecast, By Application
10.4.9.4. Market Size and Forecast, By End User
10.4.9.5. Market Size and Forecast, By Technology Type
10.4.9.6. Installed Base and Procurement Dynamics
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Market Size and Forecast, By Pump Configuration
10.4.10.3. Market Size and Forecast, By Application
10.4.10.4. Market Size and Forecast, By End User
10.4.10.5. Market Size and Forecast, By Technology Type
10.4.10.6. Installed Base and Procurement Dynamics
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Market Size and Forecast, By Pump Configuration
10.4.11.3. Market Size and Forecast, By Application
10.4.11.4. Market Size and Forecast, By End User
10.4.11.5. Market Size and Forecast, By Technology Type
10.4.11.6. Installed Base and Procurement Dynamics
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. Market Size and Forecast, By Pump Configuration
10.4.12.3. Market Size and Forecast, By Application
10.4.12.4. Market Size and Forecast, By End User
10.4.12.5. Market Size and Forecast, By Technology Type
10.4.12.6. Installed Base and Procurement Dynamics
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Market Size and Forecast, By Pump Configuration
10.4.13.3. Market Size and Forecast, By Application
10.4.13.4. Market Size and Forecast, By End User
10.4.13.5. Market Size and Forecast, By Technology Type
10.4.13.6. Installed Base and Procurement Dynamics
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. Market Size and Forecast, By Pump Configuration
10.4.14.3. Market Size and Forecast, By Application
10.4.14.4. Market Size and Forecast, By End User
10.4.14.5. Market Size and Forecast, By Technology Type
10.4.14.6. Installed Base and Procurement Dynamics
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Market Size and Forecast, By Pump Configuration
10.4.15.3. Market Size and Forecast, By Application
10.4.15.4. Market Size and Forecast, By End User
10.4.15.5. Market Size and Forecast, By Technology Type
10.4.15.6. Installed Base and Procurement Dynamics
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Market Size and Forecast, By Pump Configuration
10.4.16.3. Market Size and Forecast, By Application
10.4.16.4. Market Size and Forecast, By End User
10.4.16.5. Market Size and Forecast, By Technology Type
10.4.16.6. Installed Base and Procurement Dynamics
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Market Size and Forecast, By Pump Configuration
10.4.17.3. Market Size and Forecast, By Application
10.4.17.4. Market Size and Forecast, By End User
10.4.17.5. Market Size and Forecast, By Technology Type
10.4.17.6. Installed Base and Procurement Dynamics
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Market Size and Forecast, By Pump Configuration
10.4.18.3. Market Size and Forecast, By Application
10.4.18.4. Market Size and Forecast, By End User
10.4.18.5. Market Size and Forecast, By Technology Type
10.4.18.6. Installed Base and Procurement Dynamics
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Market Size and Forecast, By Pump Configuration
10.4.19.3. Market Size and Forecast, By Application
10.4.19.4. Market Size and Forecast, By End User
10.4.19.5. Market Size and Forecast, By Technology Type
10.4.19.6. Installed Base and Procurement Dynamics
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Market Size and Forecast, By Pump Configuration
10.4.20.3. Market Size and Forecast, By Application
10.4.20.4. Market Size and Forecast, By End User
10.4.20.5. Market Size and Forecast, By Technology Type
10.4.20.6. Installed Base and Procurement Dynamics
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Market Size and Forecast, By Pump Configuration
10.4.21.3. Market Size and Forecast, By Application
10.4.21.4. Market Size and Forecast, By End User
10.4.21.5. Market Size and Forecast, By Technology Type
10.4.21.6. Installed Base and Procurement Dynamics
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Market Size and Forecast, By Pump Configuration
10.4.22.3. Market Size and Forecast, By Application
10.4.22.4. Market Size and Forecast, By End User
10.4.22.5. Market Size and Forecast, By Technology Type
10.4.22.6. Installed Base and Procurement Dynamics
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. Market Size and Forecast, By Pump Configuration
10.4.23.3. Market Size and Forecast, By Application
10.4.23.4. Market Size and Forecast, By End User
10.4.23.5. Market Size and Forecast, By Technology Type
10.4.23.6. Installed Base and Procurement Dynamics
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035
10.5.4. Midwest Region Market Size and Forecast, By Pump Configuration, 2021–2035
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035
10.5.8. Midwest Region Installed Base, Fleet Replacement and Procurement Dynamics
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Market Size and Forecast, By Pump Configuration
10.5.9.3. Market Size and Forecast, By Application
10.5.9.4. Market Size and Forecast, By End User
10.5.9.5. Market Size and Forecast, By Technology Type
10.5.9.6. Installed Base and Procurement Dynamics
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Market Size and Forecast, By Pump Configuration
10.5.10.3. Market Size and Forecast, By Application
10.5.10.4. Market Size and Forecast, By End User
10.5.10.5. Market Size and Forecast, By Technology Type
10.5.10.6. Installed Base and Procurement Dynamics
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Market Size and Forecast, By Pump Configuration
10.5.11.3. Market Size and Forecast, By Application
10.5.11.4. Market Size and Forecast, By End User
10.5.11.5. Market Size and Forecast, By Technology Type
10.5.11.6. Installed Base and Procurement Dynamics
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Market Size and Forecast, By Pump Configuration
10.5.12.3. Market Size and Forecast, By Application
10.5.12.4. Market Size and Forecast, By End User
10.5.12.5. Market Size and Forecast, By Technology Type
10.5.12.6. Installed Base and Procurement Dynamics
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Market Size and Forecast, By Pump Configuration
10.5.13.3. Market Size and Forecast, By Application
10.5.13.4. Market Size and Forecast, By End User
10.5.13.5. Market Size and Forecast, By Technology Type
10.5.13.6. Installed Base and Procurement Dynamics
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Market Size and Forecast, By Pump Configuration
10.5.14.3. Market Size and Forecast, By Application
10.5.14.4. Market Size and Forecast, By End User
10.5.14.5. Market Size and Forecast, By Technology Type
10.5.14.6. Installed Base and Procurement Dynamics
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Market Size and Forecast, By Pump Configuration
10.5.15.3. Market Size and Forecast, By Application
10.5.15.4. Market Size and Forecast, By End User
10.5.15.5. Market Size and Forecast, By Technology Type
10.5.15.6. Installed Base and Procurement Dynamics
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Market Size and Forecast, By Pump Configuration
10.5.16.3. Market Size and Forecast, By Application
10.5.16.4. Market Size and Forecast, By End User
10.5.16.5. Market Size and Forecast, By Technology Type
10.5.16.6. Installed Base and Procurement Dynamics
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Market Size and Forecast, By Pump Configuration
10.5.17.3. Market Size and Forecast, By Application
10.5.17.4. Market Size and Forecast, By End User
10.5.17.5. Market Size and Forecast, By Technology Type
10.5.17.6. Installed Base and Procurement Dynamics
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Market Size and Forecast, By Pump Configuration
10.5.18.3. Market Size and Forecast, By Application
10.5.18.4. Market Size and Forecast, By End User
10.5.18.5. Market Size and Forecast, By Technology Type
10.5.18.6. Installed Base and Procurement Dynamics
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. Market Size and Forecast, By Pump Configuration
10.5.19.3. Market Size and Forecast, By Application
10.5.19.4. Market Size and Forecast, By End User
10.5.19.5. Market Size and Forecast, By Technology Type
10.5.19.6. Installed Base and Procurement Dynamics
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. Market Size and Forecast, By Pump Configuration
10.5.20.3. Market Size and Forecast, By Application
10.5.20.4. Market Size and Forecast, By End User
10.5.20.5. Market Size and Forecast, By Technology Type
10.5.20.6. Installed Base and Procurement Dynamics
What this section provides: This section provides detailed U.S. regional and state-level market analysis covering all 50 states, allowing clients to identify hospital infrastructure hubs, smart-pump adoption hotspots, installed-base replacement opportunities, IDN procurement concentrations and priority commercial territories.
11. U.S. Volumetric Infusion Pumps Market: Competitive Landscape & Company Profiles
11.1. Market Share Analysis, 2025
11.2. Installed Base Share Analysis
11.3. New Placement and Fleet Conversion Analysis
11.4. Competitive Benchmarking by Pump Platform
11.5. Competitive Benchmarking by Smart Pump Capability
11.6. Competitive Benchmarking by EHR Interoperability
11.7. Competitive Benchmarking by Administration Set Portfolio
11.8. Competitive Benchmarking by Service and Support Capability
11.9. Company Positioning Matrix
11.9.1. Market Leaders
11.9.2. Established Challengers
11.9.3. Technology Innovators
11.9.4. Emerging and Specialist Participants
11.10. Company Profiles
11.10.1. Becton, Dickinson and Company
11.10.2. Baxter International Inc.
11.10.3. ICU Medical, Inc.
11.10.4. B. Braun Medical Inc.
11.10.5. Fresenius Kabi
11.10.6. Terumo Corporation
11.10.7. Eitan Medical
11.10.8. Zyno Medical
11.10.9. Moog Inc.
11.10.10. Mindray North America
11.10.11. Nipro Corporation
11.10.12. Avanos Medical, Inc.
11.10.13. CODAN Companies
11.10.14. Vygon
11.10.15. Medline Industries, LP
11.10.16. Cardinal Health, Inc.
11.10.17. McKesson Medical-Surgical
11.10.18. Owens & Minor, Inc.
11.10.19. InfuSystem Holdings, Inc.
11.10.20. Agiliti Health, Inc.
11.10.21. TRIMEDX
11.10.22. PartsSource
Note: Each company profile will include company overview, volumetric infusion and infusion-management portfolio, U.S. market positioning, major pump platforms, smart-pump capabilities, interoperability strategy, administration-set ecosystem, regulatory updates, strategic partnerships, fleet conversion opportunities and recent developments.
What this section provides: This section gives clients market-share visibility, competitive benchmarking, installed-base intelligence, pump-platform positioning and strategic analysis of major manufacturers and supporting infusion ecosystem participants.
12. U.S. Volumetric Infusion Pumps Market: Future Market Outlook, 2026–2035
12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Bidirectional Smart Pump Interoperability
12.2.2. Closed-Loop Medication Administration
12.2.3. Cloud-Based Infusion Management
12.2.4. AI-Assisted Drug Library Analytics
12.2.5. Predictive Pump Fleet Management
12.2.6. Advanced Cybersecurity Architecture
12.2.7. Next-Generation Alarm Management
12.2.8. Connected Infusion and Medication Safety Platforms
12.3. Future Pump Replacement Cycle Outlook
12.4. Future Administration Set Revenue Opportunity
12.5. Future Hospital IT Integration Requirements
12.6. Emerging Business Models
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. High-Growth State Opportunity Matrix
12.10. Hospital Fleet Conversion Opportunity Matrix
What this section provides: This section prepares clients for future technology shifts, fleet replacement cycles, interoperability requirements, evolving revenue models and market adoption scenarios through 2035.
13. U.S. Volumetric Infusion Pumps Market: Strategic Recommendations
13.1. Recommendations for Volumetric Infusion Pump Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Hospital Pharmacy and Medication Safety Teams
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for Infusion Set and Disposable Manufacturers
13.7. Recommendations for Healthcare IT and Interoperability Vendors
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. Hospital Enterprise Account Prioritization
13.11. Product Positioning and Portfolio Expansion Guidance
13.12. Smart Pump Interoperability Strategy
13.13. Administration Set and Recurring Revenue Strategy
13.14. Fleet Conversion and Competitive Displacement Strategy
13.15. State-Level Commercial Prioritization Strategy
What this section provides: This section converts the market intelligence into actionable recommendations for product strategy, enterprise hospital targeting, fleet conversion, recurring revenue growth, interoperability development and geographic expansion.
14. U.S. Volumetric Infusion Pumps Market: Disclaimer
14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Sizing Limitation
14.4. Installed-Base Estimation Limitation
14.5. Forecasting Limitation
14.6. Regulatory and Product Recall Information Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s scope, data limitations, market-sizing methodology boundaries, installed-base assumptions, forecast limitations and legal conditions.
List of Tables
TABLE 1: List of Data Sources
TABLE 2: U.S. Volumetric Infusion Pumps Market: Market Definition and Scope
TABLE 3: U.S. Volumetric Infusion Pumps Market: Research Methodology Framework
TABLE 4: U.S. Volumetric Infusion Pumps Market: Key Assumptions
TABLE 5: U.S. Volumetric Infusion Pumps Market: Market Ecosystem Overview
TABLE 6: U.S. Volumetric Infusion Pumps Market: Stakeholder Analysis
TABLE 7: U.S. Volumetric Infusion Pumps Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Volumetric Infusion Pumps Market: Analyst Viewpoint Summary
TABLE 9: U.S. Volumetric Infusion Pumps Market: Market Attractiveness Index
TABLE 10: U.S. Volumetric Infusion Pumps Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Volumetric Infusion Pumps Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Volumetric Infusion Pumps Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Volumetric Infusion Pumps Market: Installed Pump Fleet Assessment, 2025
TABLE 14: U.S. Volumetric Infusion Pumps Market: Smart and Connected Pump Adoption Snapshot, 2025
TABLE 15: U.S. Volumetric Infusion Pumps Market: High-Growth Opportunity Areas, 2026–2035
TABLE 16: U.S. Volumetric Infusion Pumps Market: Drivers; Impact Analysis
TABLE 17: U.S. Volumetric Infusion Pumps Market: Restraints; Impact Analysis
TABLE 18: U.S. Volumetric Infusion Pumps Market: Opportunities; Impact Analysis
TABLE 19: U.S. Volumetric Infusion Pumps Market: Challenges; Impact Analysis
TABLE 20: U.S. Volumetric Infusion Pumps Market: Patent & Innovation Analysis, 2021–2025
TABLE 21: U.S. Volumetric Infusion Pumps Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. Volumetric Infusion Pumps Market: Nursing Productivity Impact Matrix
TABLE 23: U.S. Volumetric Infusion Pumps Market: Medication Safety Economics Matrix
TABLE 24: U.S. Volumetric Infusion Pumps Market: Hospital Capital Procurement Behavior Matrix
TABLE 25: U.S. Volumetric Infusion Pumps Market: Pump Fleet Replacement Cycle Analysis
TABLE 26: U.S. Volumetric Infusion Pumps Market: Installed Base versus New Placement Opportunity Analysis
TABLE 27: U.S. Volumetric Infusion Pumps Market: PESTEL Analysis
TABLE 28: U.S. Volumetric Infusion Pumps Market: Porter’s Five Forces Analysis
TABLE 29: U.S. Volumetric Infusion Pumps Market: Pump Pricing Trend Analysis, 2025–2035
TABLE 30: U.S. Volumetric Infusion Pumps Market: Administration Set Pricing Trend Analysis
TABLE 31: U.S. Volumetric Infusion Pumps Market: Value Chain Analysis
TABLE 32: U.S. Volumetric Infusion Pumps Market: Supply Chain Analysis
TABLE 33: U.S. Volumetric Infusion Pumps Market: Smart Hospital Digitalization Impact
TABLE 34: U.S. Volumetric Infusion Pumps Market: Drug Library and Dose-Error Reduction Ecosystem
TABLE 35: U.S. Volumetric Infusion Pumps Market: EHR and Pharmacy System Interoperability Landscape
TABLE 36: U.S. Volumetric Infusion Pumps Market: FDA Regulatory Framework Analysis
TABLE 37: U.S. Volumetric Infusion Pumps Market: FDA Safety, Recall and Field Correction Landscape
TABLE 38: U.S. Volumetric Infusion Pumps Market: Medical Device Cybersecurity Requirements
TABLE 39: U.S. Volumetric Infusion Pumps Market: CMS Reimbursement and Hospital Payment Environment
TABLE 40: U.S. Volumetric Infusion Pumps Market: Import/Export Restrictions & Tariff Impact
TABLE 41: U.S. Volumetric Infusion Pumps Market: Government Healthcare and Medication Safety Initiatives
TABLE 42: U.S. Volumetric Infusion Pumps Market: Impact of Geopolitical and Supply Chain Tensions
TABLE 43: U.S. Volumetric Infusion Pumps Market: Hospital Value Analysis Committee Decision Framework
TABLE 44: U.S. Volumetric Infusion Pumps Market: Total Cost of Ownership Analysis
TABLE 45: U.S. Volumetric Infusion Pumps Market: Pump Hardware versus Disposable Revenue Economics
TABLE 46: U.S. Volumetric Infusion Pumps Market: Pump Configuration Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Pump Configuration
TABLE 48: U.S. Volumetric Infusion Pumps Market, by Pump Configuration, 2021–2035 (US$ Billion)
TABLE 49: U.S. Volumetric Infusion Pumps Market: Segment Share Analysis, by Pump Configuration, 2025 & 2035 (%)
TABLE 50: U.S. Volumetric Infusion Pumps Market: Standalone Single-Channel Volumetric Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Volumetric Infusion Pumps Market: Modular Multi-Channel Volumetric Infusion Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Volumetric Infusion Pumps Market: Smart Large-Volume Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Volumetric Infusion Pumps Market: Transport-Capable Volumetric Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Volumetric Infusion Pumps Market: Specialty and High-Acuity Volumetric Infusion Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Volumetric Infusion Pumps Market: Application Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by Application
TABLE 57: U.S. Volumetric Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 58: U.S. Volumetric Infusion Pumps Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 59: U.S. Volumetric Infusion Pumps Market: IV Fluids and Hydration Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Volumetric Infusion Pumps Market: Antibiotics and Anti-Infective Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Volumetric Infusion Pumps Market: Oncology and Chemotherapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Volumetric Infusion Pumps Market: Parenteral Nutrition Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Volumetric Infusion Pumps Market: Critical Care and Vasoactive Drug Administration Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Volumetric Infusion Pumps Market: Blood and Blood Product Administration Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Volumetric Infusion Pumps Market: Perioperative and Anesthesia-Related Infusion Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Volumetric Infusion Pumps Market: Other Specialty Infusion Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Volumetric Infusion Pumps Market: End User Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by End User
TABLE 69: U.S. Volumetric Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 70: U.S. Volumetric Infusion Pumps Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 71: U.S. Volumetric Infusion Pumps Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Volumetric Infusion Pumps Market: Academic Medical Centers and Tertiary Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Volumetric Infusion Pumps Market: Outpatient Infusion and Oncology Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Volumetric Infusion Pumps Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Volumetric Infusion Pumps Market: Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Volumetric Infusion Pumps Market: Home Infusion and Alternate-Site Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Volumetric Infusion Pumps Market: Technology Type Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 79: U.S. Volumetric Infusion Pumps Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 80: U.S. Volumetric Infusion Pumps Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 81: U.S. Volumetric Infusion Pumps Market: Conventional Electronic Volumetric Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Volumetric Infusion Pumps Market: Smart Pumps with Dose-Error Reduction Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Volumetric Infusion Pumps Market: Wireless Connected Infusion Pumps Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Volumetric Infusion Pumps Market: EHR-Interoperable Volumetric Infusion Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Volumetric Infusion Pumps Market: Advanced Analytics and Fleet-Management Enabled Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Volumetric Infusion Pumps Market: Procurement & Commercial Model Overview, 2025
TABLE 87: U.S. Volumetric Infusion Pumps Market: Direct Hospital and Health System Procurement Analysis
TABLE 88: U.S. Volumetric Infusion Pumps Market: Integrated Delivery Network Enterprise Contract Analysis
TABLE 89: U.S. Volumetric Infusion Pumps Market: Group Purchasing Organization Influence
TABLE 90: U.S. Volumetric Infusion Pumps Market: Distributor and Specialty Medical Supplier Channel Analysis
TABLE 91: U.S. Volumetric Infusion Pumps Market: Capital Purchase, Rental and Equipment-as-a-Service Comparison
TABLE 92: U.S. Volumetric Infusion Pumps Market: Disposable Commitment and Pump Placement Agreement Analysis
TABLE 93: U.S. Volumetric Infusion Pumps Market: Hospital RFP and Vendor Selection Criteria
TABLE 94: U.S. Volumetric Infusion Pumps Market: Total Cost of Ownership Benchmarking
TABLE 95: U.S. Volumetric Infusion Pumps Market: Regional Snapshot, 2025
TABLE 96: Segment Dashboard; Definition and Scope, by Geography
TABLE 97: U.S. Volumetric Infusion Pumps Market, by Geography, 2021–2035 (US$ Billion)
TABLE 98: U.S. Volumetric Infusion Pumps Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 99: West Region U.S. Volumetric Infusion Pumps Market: Regional Overview and Trends
TABLE 100: West Region U.S. Volumetric Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 101: West Region U.S. Volumetric Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Volumetric Infusion Pumps Market, by Pump Configuration, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Volumetric Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Volumetric Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 105: West Region U.S. Volumetric Infusion Pumps Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 106: West Region U.S. Volumetric Infusion Pumps Market: Installed Base, Fleet Replacement and Procurement Dynamics
TABLE 107: California Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 108: Washington Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 109: Arizona Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 110: Colorado Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 111: Oregon Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 112: Utah Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 113: Nevada Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 114: New Mexico Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 115: Idaho Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 116: Montana Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 117: Wyoming Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 118: Alaska Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 119: Hawaii Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region U.S. Volumetric Infusion Pumps Market: Regional Overview and Trends
TABLE 121: Northeast Region U.S. Volumetric Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 122: Northeast Region U.S. Volumetric Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 123: Northeast Region U.S. Volumetric Infusion Pumps Market, by Pump Configuration, 2021–2035 (US$ Billion)
TABLE 124: Northeast Region U.S. Volumetric Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 125: Northeast Region U.S. Volumetric Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 126: Northeast Region U.S. Volumetric Infusion Pumps Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 127: Northeast Region U.S. Volumetric Infusion Pumps Market: Installed Base, Fleet Replacement and Procurement Dynamics
TABLE 128: New York Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 129: Massachusetts Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 130: New Jersey Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 131: Pennsylvania Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 132: Connecticut Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 133: Maine Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 134: Vermont Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 135: New Hampshire Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 136: Rhode Island Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 137: Delaware Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 138: South Region U.S. Volumetric Infusion Pumps Market: Regional Overview and Trends
TABLE 139: South Region U.S. Volumetric Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 140: South Region U.S. Volumetric Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 141: South Region U.S. Volumetric Infusion Pumps Market, by Pump Configuration, 2021–2035 (US$ Billion)
TABLE 142: South Region U.S. Volumetric Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: South Region U.S. Volumetric Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: South Region U.S. Volumetric Infusion Pumps Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 145: South Region U.S. Volumetric Infusion Pumps Market: Installed Base, Fleet Replacement and Procurement Dynamics
TABLE 146: Texas Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 147: Florida Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 148: Georgia Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 149: North Carolina Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 150: Tennessee Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 151: South Carolina Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 152: Alabama Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 153: Mississippi Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 154: Louisiana Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 155: Arkansas Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 156: Kentucky Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 157: Oklahoma Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 158: Virginia Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 159: Maryland Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 160: West Virginia Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region U.S. Volumetric Infusion Pumps Market: Regional Overview and Trends
TABLE 162: Midwest Region U.S. Volumetric Infusion Pumps Market: Key Manufacturers and Procurement Ecosystem
TABLE 163: Midwest Region U.S. Volumetric Infusion Pumps Market, by State, 2021–2035 (US$ Billion)
TABLE 164: Midwest Region U.S. Volumetric Infusion Pumps Market, by Pump Configuration, 2021–2035 (US$ Billion)
TABLE 165: Midwest Region U.S. Volumetric Infusion Pumps Market, by Application, 2021–2035 (US$ Billion)
TABLE 166: Midwest Region U.S. Volumetric Infusion Pumps Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: Midwest Region U.S. Volumetric Infusion Pumps Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 168: Midwest Region U.S. Volumetric Infusion Pumps Market: Installed Base, Fleet Replacement and Procurement Dynamics
TABLE 169: Illinois Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 170: Ohio Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 171: Michigan Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 172: Minnesota Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 173: Indiana Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 174: Wisconsin Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 175: Missouri Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 176: Iowa Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 177: Kansas Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 178: Nebraska Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 179: North Dakota Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 180: South Dakota Volumetric Infusion Pumps Market: Market Size, Forecast and Key Demand Indicators, 2021–2035 (US$ Billion)
TABLE 181: U.S. Volumetric Infusion Pumps Market: Competitive Landscape Snapshot, 2025
TABLE 182: U.S. Volumetric Infusion Pumps Market: Key Company Market Share Analysis, 2025
TABLE 183: U.S. Volumetric Infusion Pumps Market: Installed Base Share Analysis, 2025
TABLE 184: U.S. Volumetric Infusion Pumps Market: New Placement and Fleet Conversion Analysis
TABLE 185: U.S. Volumetric Infusion Pumps Market: Company Positioning Matrix
TABLE 186: U.S. Volumetric Infusion Pumps Market: Smart Pump Capability Benchmarking
TABLE 187: U.S. Volumetric Infusion Pumps Market: EHR Interoperability Benchmarking
TABLE 188: U.S. Volumetric Infusion Pumps Market: Administration Set Portfolio Benchmarking
TABLE 189: U.S. Volumetric Infusion Pumps Market: Service and Support Capability Benchmarking
TABLE 190: U.S. Volumetric Infusion Pumps Market: Strategic Developments, Partnerships, Product Launches and Regulatory Updates
TABLE 191: Becton, Dickinson and Company: Company Profile
TABLE 192: Baxter International Inc.: Company Profile
TABLE 193: ICU Medical, Inc.: Company Profile
TABLE 194: B. Braun Medical Inc.: Company Profile
TABLE 195: Fresenius Kabi: Company Profile
TABLE 196: Terumo Corporation: Company Profile
TABLE 197: Eitan Medical: Company Profile
TABLE 198: Zyno Medical: Company Profile
TABLE 199: Moog Inc.: Company Profile
TABLE 200: Mindray North America: Company Profile
TABLE 201: Nipro Corporation: Company Profile
TABLE 202: Avanos Medical, Inc.: Company Profile
TABLE 203: CODAN Companies: Company Profile
TABLE 204: Vygon: Company Profile
TABLE 205: Medline Industries, LP: Company Profile
TABLE 206: Cardinal Health, Inc.: Company Profile
TABLE 207: McKesson Medical-Surgical: Company Profile
TABLE 208: Owens & Minor, Inc.: Company Profile
TABLE 209: InfuSystem Holdings, Inc.: Company Profile
TABLE 210: Agiliti Health, Inc.: Company Profile
TABLE 211: TRIMEDX: Company Profile
TABLE 212: PartsSource: Company Profile
TABLE 213: U.S. Volumetric Infusion Pumps Market: Future Market Scenario Analysis, 2026–2035
TABLE 214: U.S. Volumetric Infusion Pumps Market: Disruptive Technologies Impact Matrix
TABLE 215: U.S. Volumetric Infusion Pumps Market: Future Pump Replacement Cycle Outlook
TABLE 216: U.S. Volumetric Infusion Pumps Market: Future Administration Set Revenue Opportunity
TABLE 217: U.S. Volumetric Infusion Pumps Market: Emerging Business Models
TABLE 218: U.S. Volumetric Infusion Pumps Market: Business Opportunities for Startups and Existing Players
TABLE 219: U.S. Volumetric Infusion Pumps Market: Investment Prioritization Matrix
TABLE 220: U.S. Volumetric Infusion Pumps Market: High-Growth State Opportunity Matrix
TABLE 221: U.S. Volumetric Infusion Pumps Market: Hospital Fleet Conversion Opportunity Matrix
TABLE 222: U.S. Volumetric Infusion Pumps Market: Strategic Recommendations for Manufacturers
TABLE 223: U.S. Volumetric Infusion Pumps Market: Strategic Recommendations for Hospitals and IDNs
TABLE 224: U.S. Volumetric Infusion Pumps Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 225: U.S. Volumetric Infusion Pumps Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 226: U.S. Volumetric Infusion Pumps Market: Strategic Recommendations for Healthcare IT and Interoperability Vendors
TABLE 227: U.S. Volumetric Infusion Pumps Market: Strategic Recommendations for New Entrants and Startups
TABLE 228: U.S. Volumetric Infusion Pumps Market: Go-to-Market Strategy Considerations
TABLE 229: U.S. Volumetric Infusion Pumps Market: Fleet Conversion and Competitive Displacement Strategy
TABLE 230: U.S. Volumetric Infusion Pumps Market: Product Positioning and Portfolio Expansion Guidance
TABLE 231: U.S. Volumetric Infusion Pumps Market: Scope Limitation
TABLE 232: U.S. Volumetric Infusion Pumps Market: Data Use Limitation
TABLE 233: U.S. Volumetric Infusion Pumps Market: Market Sizing Limitation
TABLE 234: U.S. Volumetric Infusion Pumps Market: Installed-Base Estimation Limitation
TABLE 235: U.S. Volumetric Infusion Pumps Market: Forecasting Limitation
TABLE 236: U.S. Volumetric Infusion Pumps Market: Regulatory and Product Recall Information Limitation
TABLE 237: U.S. Volumetric Infusion Pumps Market: Legal Disclaimer
TABLE 238: U.S. Volumetric Infusion Pumps Market: Third-Party Data Disclaimer
List of Figures
FIGURE 1: U.S. Volumetric Infusion Pumps Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Market Attractiveness Analysis
FIGURE 5: U.S. Volumetric Infusion Pumps Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 6: U.S. Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Volumetric Infusion Pumps Market Year-wise Growth Curve, 2021–2035
FIGURE 8: U.S. Volumetric Infusion Pumps Installed Base and Smart Pump Adoption Framework, 2025
FIGURE 9: U.S. Volumetric Infusion Pumps Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Nursing Productivity and Medication Safety Impact Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: Volumetric Infusion Pump Fleet Replacement Cycle
FIGURE 15: Installed Base versus New Placement Opportunity Map
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: Drug Library and Dose-Error Reduction Ecosystem
FIGURE 21: EHR and Pharmacy Interoperability Framework
FIGURE 22: FDA Safety, Recall and Regulatory Landscape
FIGURE 23: Cybersecurity Requirements Framework
FIGURE 24: Hospital Value Analysis Committee Decision Framework
FIGURE 25: Total Cost of Ownership Framework
FIGURE 26: Pump Configuration Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Pump Configuration Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Standalone Single-Channel Volumetric Pumps Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 29: Modular Multi-Channel Volumetric Infusion Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 30: Smart Large-Volume Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 31: Transport-Capable Volumetric Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 32: Specialty and High-Acuity Volumetric Infusion Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 33: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 34: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: IV Fluids and Hydration Therapy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 36: Antibiotics and Anti-Infective Therapy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Oncology and Chemotherapy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: Parenteral Nutrition Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 39: Critical Care and Vasoactive Drug Administration Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: Blood and Blood Product Administration Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 41: Perioperative and Anesthesia-Related Infusion Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 42: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 43: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 45: Academic Medical Centers and Tertiary Hospitals Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 46: Outpatient Infusion and Oncology Centers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 47: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 48: Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 49: Home Infusion and Alternate-Site Care Providers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 50: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Conventional Electronic Volumetric Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 53: Smart Pumps with Dose-Error Reduction Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 54: Wireless Connected Infusion Pumps Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 55: EHR-Interoperable Volumetric Infusion Platforms Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 56: Advanced Analytics and Fleet-Management Enabled Platforms Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 57: U.S. Volumetric Infusion Pumps Procurement and Commercial Model Framework
FIGURE 58: Hospital Enterprise Contracting and GPO Influence Framework
FIGURE 59: Capital Purchase versus Rental and Equipment-as-a-Service Model
FIGURE 60: Disposable Commitment and Pump Placement Agreement Economics
FIGURE 61: Hospital RFP and Vendor Selection Framework
FIGURE 62: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 63: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: West Region U.S. Volumetric Infusion Pumps Market Share and Competitive Landscape, 2025
FIGURE 65: West Region Market Share Analysis by State, 2025
FIGURE 66: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: California Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Washington Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Arizona Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Colorado Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Oregon Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Utah Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Nevada Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: New Mexico Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Idaho Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Montana Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Wyoming Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Alaska Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Hawaii Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Northeast Region U.S. Volumetric Infusion Pumps Market Share and Competitive Landscape, 2025
FIGURE 81: Northeast Region Market Share Analysis by State, 2025
FIGURE 82: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New York Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Massachusetts Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: New Jersey Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Pennsylvania Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Connecticut Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Maine Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Vermont Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: New Hampshire Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Rhode Island Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Delaware Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Region U.S. Volumetric Infusion Pumps Market Share and Competitive Landscape, 2025
FIGURE 94: South Region Market Share Analysis by State, 2025
FIGURE 95: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Texas Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Florida Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Georgia Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: North Carolina Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Tennessee Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: South Carolina Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Alabama Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Mississippi Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Louisiana Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Arkansas Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Kentucky Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Oklahoma Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Virginia Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Maryland Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: West Virginia Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Midwest Region U.S. Volumetric Infusion Pumps Market Share and Competitive Landscape, 2025
FIGURE 112: Midwest Region Market Share Analysis by State, 2025
FIGURE 113: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Illinois Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Ohio Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Michigan Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Minnesota Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Indiana Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Wisconsin Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Missouri Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Iowa Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Kansas Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Nebraska Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: North Dakota Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 125: South Dakota Volumetric Infusion Pumps Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 126: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 127: Installed Base Share Analysis by Key Company, 2025
FIGURE 128: Company Positioning Matrix
FIGURE 129: Smart Pump Capability Benchmarking
FIGURE 130: EHR Interoperability Benchmarking
FIGURE 131: Administration Set Portfolio Benchmarking
FIGURE 132: Strategic Developments, Partnerships, Product Launches and Regulatory Updates
FIGURE 133: Volumetric Infusion Pump Innovation Roadmap
FIGURE 134: Bidirectional Smart Pump Interoperability Adoption Roadmap
FIGURE 135: Connected Infusion and Medication Safety Platform Opportunity Map
FIGURE 136: Future Market Scenario Analysis, 2026–2035
FIGURE 137: Disruptive Technologies Impact Matrix
FIGURE 138: Future Pump Replacement Cycle Outlook
FIGURE 139: Future Administration Set Revenue Opportunity
FIGURE 140: Emerging Business Models Matrix
FIGURE 141: Investment Prioritization Matrix
FIGURE 142: High-Growth State Opportunity Map
FIGURE 143: Hospital Fleet Conversion Opportunity Matrix
FIGURE 144: Strategic Growth Roadmap for U.S. Volumetric Infusion Pump Companies
FIGURE 145: Go-to-Market Strategy Framework
FIGURE 146: Fleet Conversion and Competitive Displacement Framework
FIGURE 147: Product Positioning and Portfolio Expansion Framework
FIGURE 148: Report Scope and Disclaimer Framework